Replies to post #206693 on Biotech Values

[DewDiligence]

PTHN—...but earnings were nowhere [near] what I expected. I'm guessing that there were many one time items listed that should disappear over time.

Are you talking about the banking and legal expenses of going public? If not that, then what?

I deal with them and can attest they are a first class operation, and I don't see any downside to speak of.

Thanks—that's good to know. How long have you had a business relationship with the company?

[DewDiligence]

PTHN’s prepared statement on JPM webcast was almost a verbatim copy of the introductory statement of #board-15427.

[DewDiligence]

PTHN completes purchase of South Carolina manufacturing plant from Roche; it will be used for small-molecule drugs and API:

http://finance.yahoo.com/news/patheon-announces-completion-acquisition-state-140000732.html

Good timing politically.

[DewDiligence]

PTHN -15% on soft FY1Q17 results:

http://finance.yahoo.com/news/patheon-reports-fiscal-2017-first-103000602.html

Comments?